|
|
||||||||
Radiology, Vol 180, 85-89, Copyright © 1991 by Radiological Society of North America
ARTICLES |
NM Rofsky, JC Weinreb, MA Bosniak, RB Libes and BA Birnbaum
Department of Radiology, New York University School of Medicine, New York, University Medical Center, NY 10016.
Five patients with renal insufficiency were studied with T1-weighted magnetic resonance (MR) imaging before and after intravenous administration of gadopentetate dimeglumine (0.1 mmol/kg) to characterize renal lesions that were detected with nonenhanced computed tomography (CT) and were considered indeterminate. Four patients demonstrated renal lesions that enhanced after gadolinium administration. A total of five lesions in these four patients were surgically resected and found to be renal cell carcinoma at pathologic examination. The fifth patient was spared surgery because a hyperattenuated lesion noted at nonenhanced CT did not enhance with intravenous gadolinium, indicating a benign cyst. Five incidentally occurring benign cysts removed at the time of nephrectomy in two of the patients did not demonstrate enhancement with gadolinium on MR images. Serial serum creatine levels were obtained before and after gadolinium administration in all patients; no changes were noted after gadolinium administration. Gadolinium-enhanced MR imaging is an effective method for characterizing renal lesions in patients with renal insufficiency. At the usual dosage, there appears to be no nephrotoxic reaction in these patients.
This article has been cited by other articles:
![]() |
J. C. Weinreb Which Study When? Is Gadolinium-enhanced MR Imaging Safer than Iodine-enhanced CT? Radiology, October 1, 2008; 249(1): 3 - 8. [Full Text] [PDF] |
||||
![]() |
S. G. Silverman, G. M. Israel, B. R. Herts, and J. P. Richie Management of the Incidental Renal Mass Radiology, October 1, 2008; 249(1): 16 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Colletti Nephrogenic Systemic Fibrosis and Gadolinium: A Perfect Storm Am. J. Roentgenol., October 1, 2008; 191(4): 1150 - 1153. [Full Text] [PDF] |
||||
![]() |
M. A. Perazella How Should Nephrologists Approach Gadolinium-based Contrast Imaging in Patients with Kidney Disease? Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 649 - 651. [Full Text] [PDF] |
||||
![]() |
M. J. Gandhi, V. R. Narra, J. J. Brown, A. Guo, D. S. Grosu, C. A. Parvin, and M. G. Scott Clinical and Economic Impact of Falsely Decreased Calcium Values Caused by Gadoversetamide Interference Am. J. Roentgenol., March 1, 2008; 190(3): W213 - W217. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Mannebach, R. S. Dieter, and D. S. Marks Use of Gadolinium-Based Angiography for Renal Artery Stenting in a Patient With Renal Insufficiency: A Case Report Angiology, August 1, 2006; 57(4): 526 - 529. [Abstract] [PDF] |
||||
![]() |
R. Katz-Brull, N. M. Rofsky, M. M. Morrin, I. Pedrosa, D. J. George, M. D. Michaelson, R. P. Marquis, M. Maril, C. Noguera, and R. E. Lenkinski Decreases in free cholesterol and fatty acid unsaturation in renal cell carcinoma demonstrated by breath-hold magnetic resonance spectroscopy Am J Physiol Renal Physiol, April 1, 2005; 288(4): F637 - F641. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Kang, M. G. Scott, B. N. Joe, V. Narra, J. Heiken, and C. A. Parvin Model for Predicting the Impact of Gadolinium on Plasma Calcium Measured by the o-Cresolphthalein Method Clin. Chem., April 1, 2004; 50(4): 741 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Prince, H. E. Erel, R. W. Lent, J. Blumenfeld, K. C. Kent, H. L. Bush, and Y. Wang Gadodiamide Administration Causes Spurious Hypocalcemia Radiology, June 1, 2003; 227(3): 639 - 646. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. B. Ho, S. F. Allen, M. N. Hood, and P. L. Choyke Renal Masses: Quantitative Assessment of Enhancement with Dynamic MR Imaging Radiology, September 1, 2002; 224(3): 695 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Tombach, C. Bremer, P. Reimer, F. Matzkies, R. M. Schaefer, W. Ebert, V. Geens, J. Eisele, and W. Heindel Using Highly Concentrated Gadobutrol as an MR Contrast Agent in Patients Also Requiring Hemodialysis: Safety and Dialysability Am. J. Roentgenol., January 1, 2002; 178(1): 105 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Tombach, C. Bremer, P. Reimer, K. Kisters, R. M. Schaefer, V. Geens, and W. Heindel Renal Tolerance of a Neutral Gadolinium Chelate (gadobutrol) in Patients with Chronic Renal Failure: Results of a Randomized Study Radiology, March 1, 2001; 218(3): 651 - 657. [Abstract] [Full Text] |
||||
![]() |
R. C. Semelka and T. K. G. Helmberger Contrast Agents for MR Imaging of the Liver Radiology, January 1, 2001; 218(1): 27 - 38. [Abstract] [Full Text] |
||||
![]() |
B. L. KASISKE, M. A. VAZQUEZ, W. E. HARMON, R. S. BROWN, G. M. DANOVITCH, R. S. GASTON, D. ROTH, J. D. SCANDLING JR., and G. G. SINGER Recommendations for the Outpatient Surveillance of Renal Transplant Recipients J. Am. Soc. Nephrol., October 1, 2000; 11(2007): S1 - S86. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Scialpi, A. Di Maggio, M. Midiri, A. Loperfido, G. Angelelli, and A. Rotondo Small Renal Masses: Assessment of Lesion Characterization and Vascularity on Dynamic Contrast-Enhanced MR Imaging with Fat Suppression Am. J. Roentgenol., September 1, 2000; 175(3): 751 - 757. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Heiss, R. Y. Shifrin, and F. G. Sommer Contrast-enhanced Three-dimensional Fast Spoiled Gradient-Echo Renal MR Imaging: Evaluation of Vascular and Nonvascular Disease RadioGraphics, September 1, 2000; 20(5): 1341 - 1352. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Tello, B. D. Davison, M. O'Malley, H. Fenlon, K. R. Thomson, D. J. Witte, and L. Harewood MR Imaging of Renal Masses Interpreted on CT to Be Suspicious Am. J. Roentgenol., April 1, 2000; 174(4): 1017 - 1022. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Rofsky and M. A. Adelman MR Angiography in the Evaluation of Atherosclerotic Peripheral Vascular Disease Radiology, February 1, 2000; 214(2): 325 - 338. [Abstract] [Full Text] |
||||
![]() |
R. N. Low, R. C. Semelka, S. Worawattanakul, G. D. Alzate, and J. S. Sigeti Extrahepatic Abdominal Imaging in Patients with Malignancy: Comparison of MR Imaging and Helical CT, with Subsequent Surgical Correlation Radiology, March 1, 1999; 210(3): 625 - 632. [Abstract] [Full Text] |
||||
![]() |
R. J. Motzer, N. H. Bander, and D. M. Nanus Renal-Cell Carcinoma N. Engl. J. Med., September 19, 1996; 335(12): 865 - 875. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |